ZIOPHARM Oncology Inc. (ZIOP) could find an ally in its 200-day moving average ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is struggling today, despite a drug data win for the biotech stock. Earlier, ZIOP ...

ZIOPHARM Oncology, Inc. 's ZIOP shares crashed 11.6% after the company announced the death of a patient in a phase I study on its lead candidate, Ad-RTS-hIL-12, for the treatment of recurrent or ...

If you are looking for the best ideas for your portfolio you may want to consider some of Miller Value Partners top stock picks. Miller Value Partners, an investment management firm, is bullish on ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in NVIDIA Corp (Symbol: NVDA), where a total volume of 60,976 contracts has been ...

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and ...

However I also observe that ZIOP has now had a full week to supplement and expand upon that very brief initial press release, but has not yet done so. Instead we received new and unrelated information ...

Ziopharm Oncology (ZIOP) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-. Editor’s Note: Any reference to TheStreet Ratings and its underlying recommendation does ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ZIOPHARM Oncology Inc (NASD: ZIOP), where a total volume of 9,180 contracts has ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in LinkedIn Corp (NYSE: LNKD), where a total volume of 17,572 contracts has been ...

Ziopharm Oncology (ZIOP) is expected to deliver a year-over-year increase in earnings on flat revenues when it reports results for the quarter ended September 2018. This widely-known consensus outlook ...